We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Determinants of Efficacy of EsophyX Treatment in Gastro-Esophageal Reflux Disease

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2007 by Cliniques universitaires Saint-Luc- Université Catholique de Louvain.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00498082
First Posted: July 9, 2007
Last Update Posted: September 6, 2007
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
  Purpose

EsophyX is a promising endoscopic treatment for gastro-esophageal reflux disease. It is not known whether there are some pre- or per-operative anatomic or pathophysiological findings which may influence outcome.

The aim of this trial is to study a series of parameters acquired during the pre-therapeutic work-up or during the procedure and their influence on the outcome of the procedure.


Condition
Gastroesophageal Reflux Disease

Study Type: Observational
Study Design: Time Perspective: Longitudinal
Time Perspective: Prospective
Official Title: Determinants of Efficacy of EsophyX Treatment in Gastro-Esophageal Reflux Disease

Resource links provided by NLM:


Further study details as provided by Cliniques universitaires Saint-Luc- Université Catholique de Louvain:

Study Start Date: September 2007
Estimated Study Completion Date: September 2008
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 75 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients being considered for EsophyX treatment of GERD
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00498082


Contacts
Contact: Hubert Piessevaux, MD, PhD + 32 2 764 28 34 piessevaux@gaen.ucl.ac.be

Locations
Belgium
Cliniques universitaires St-Luc Recruiting
Brussels, Belgium, 1200
Principal Investigator: Hubert Piessevaux, MD, PhD         
Sponsors and Collaborators
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Investigators
Principal Investigator: Hubert Piessevaux, MD, PhD Cliniques universitaires St-Luc
  More Information

Additional Information:
ClinicalTrials.gov Identifier: NCT00498082     History of Changes
Other Study ID Numbers: UCL-STLUC-GAS-01
First Submitted: July 6, 2007
First Posted: July 9, 2007
Last Update Posted: September 6, 2007
Last Verified: September 2007

Additional relevant MeSH terms:
Gastroesophageal Reflux
Esophageal Motility Disorders
Deglutition Disorders
Esophageal Diseases
Gastrointestinal Diseases
Digestive System Diseases